MFAM
PTCT icon

Motley Fool Asset Management’s PTC Therapeutics PTCT Stock Holding History

Motley Fool Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-39,390
Closed -$1.6M – 224
2023
Q2 		$1.6M Sell
39,390
-390
-1% -$19.1K 0.14% 108
2023
Q1 		$1.93M Sell
39,780
-3,116
-7% -$142K 0.21% 81
2022
Q4 		$1.64M Buy
42,896
+6,425
+18% +$267K 0.18% 95
2022
Q3 		$1.83M Sell
36,471
-1,806
-5% -$88.5K 0.18% 92
2022
Q2 		$1.68M Buy
38,277
+5,351
+16% +$188K 0.16% 103
2022
Q1 		$1.23M Sell
32,926
-110,418
-77% -$4.25M 0.09% 136
2021
Q4 		$5.71M Sell
143,344
-7,407
-5% -$283K 0.37% 73
2021
Q3 		$5.61M Buy
150,751
+22,398
+17% +$920K 0.36% 69
2021
Q2 		$5.42M Sell
128,353
-6,900
-5% -$296K 0.36% 72
2021
Q1 		$6.4M Buy
135,253
+20,700
+18% +$1.23M 0.46% 62
2020
Q4 		$6.99M Buy
114,553
+20,700
+22% +$1.22M 0.52% 56
2020
Q3 		$4.59M Buy
93,853
+28,038
+43% +$1.38M 0.41% 64
2020
Q2 		$3.34M Buy
65,815
+5,698
+9% +$280K 0.33% 62
2020
Q1 		$2.68M Buy
60,117
+9,482
+19% +$477K 0.35% 59
2019
Q4 		$2.43M Buy
50,635
+28,190
+126% +$1.2M 0.26% 72
2019
Q3 		$759K Buy
+22,445
New +$977K 0.09% 118

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Motley Fool Asset Management's PTCT Position: Q3 2023 in Review

Motley Fool Asset Management sold out of PTC Therapeutics (PTCT) in Q3 2023, closing a stake of 39,390 shares — an estimated $1.6M sold.

Motley Fool Asset Management first reported a position in PTCT in Q3 2019 and held it in 16 quarters. The position peaked at $6.99M in Q4 2020. 180 funds tracked by Wall St. Rank hold PTCT as of Q3 2023.

  • Motley Fool Asset Management reported no remaining PTC Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Motley Fool Asset Management sold 39,390 PTC Therapeutics shares in Q3 2023, an estimated $1.6M.
  • Motley Fool Asset Management first reported a position in PTC Therapeutics in Q3 2019 and held it in 16 quarters.
  • Motley Fool Asset Management's PTC Therapeutics position peaked at $6.99M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2023.

Based on Motley Fool Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.